A phase I dose escalation study of trifluridine and tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients with advanced gastrointestinal (GI) tumors Meeting Abstract


Authors: Varghese, A. M.; Cardin, D. B.; Hersch, J.; Benson, A. B.; Hochster, H. S.; Winkler, R.; Benedetti, F.; Hamada, K.; Berlin, J. D.; Saltz, L.
Abstract Title: A phase I dose escalation study of trifluridine and tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients with advanced gastrointestinal (GI) tumors
Meeting Title: 109th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 78
Issue: 13 Suppl.
Meeting Dates: 2018 Apr 14-18
Meeting Location: Chicago, IL
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-07-01
Language: English
ACCESSION: WOS:000468818900057
DOI: 10.1158/1538-7445.Am2018-ct062
PROVIDER: wos
Notes: Meeting Abstract: CT062 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    791 Saltz
  2. Anna Mary Varghese
    146 Varghese
  3. Jonathan T Hersch
    6 Hersch